INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Ipca Laboratories Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524494	ISIN Demat INE571A01038	Book Value 271.64	NSE Symbol IPCALAB	Dividend Yield (%) 0.3	Market Cap (₹ Cr.) 33,466.12	P/E 36.86	EPS 35.79	Face Value 1

Particulars (₹ Cr)	Jun 2025	Mar 2025	Dec 2024	Sep 2024

Gross Sales/Income from operations	1746.9	1638.44	1662.68	1810.94
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	1,746.90	1,638.44	1,662.68	1,810.94
Other Operating Income	0.00	0.00	0.00	0.00
Total Income from operations (net)	1,746.90	1,638.44	1,662.68	1,810.94
Total Expenses	1,403.11	1,345.04	1,314.40	1,471.48
Cost of Sales	447.89	445.52	459.26	535.94
Employee Cost	409.91	377.12	358.48	382.44
Depreciation, amortization and depletion expense	63.13	65.19	62.81	62.65
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	482.18	457.21	433.85	490.45
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	343.79	293.40	348.28	339.46
Other Income	25.02	21.49	17.41	17.00
Profit from ordinary activities before finance costs and exceptional items	368.81	314.89	365.69	356.46
Finance Costs	12.06	16.20	10.17	17.25
Profit from ordinary activities after finance costs but before exceptional items	356.75	298.69	355.52	339.21
Exceptional Items	0.00	-281.54	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	356.75	17.15	355.52	339.21
Total Tax	94.71	82.20	87.96	95.09
Net profit from Ordinary Activities After Tax	262.04	-65.05	267.56	244.12
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	262.04	-65.05	267.56	244.12
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	262.04	-65.05	267.56	244.12
Other Comprehensive Income	-1.89	2.57	-1.31	-7.64
Total Comprehensive Income	260.15	-62.48	266.25	236.48
Equity	25.37	25.37	25.37	25.37
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	10.33	8.52	10.55	9.62
EPS before Exceptional/Extraordinary items-Diluted	10.33	8.52	10.55	9.62
EPS after Exceptional/Extraordinary items-Basic	10.33	-2.56	10.55	9.62
EPS after Exceptional/Extraordinary items-Diluted	10.33	-2.56	10.55	9.62
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	2.00
Dividend (%)	0.00	0.00	0.00	200.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00